Clinical trials recruiting for Anatomic Stage IIIA Breast Cancer AJCC v8
10
Recruiting trials
49
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Pembrolizumab | 4 |
| Cyclophosphamide | 3 |
| Carboplatin | 2 |
| Doxorubicin | 2 |
| Paclitaxel | 2 |
| Anastrozole | 1 |
| Atezolizumab | 1 |
| Cabozantinib S-malate | 1 |
| Cediranib | 1 |
| Ceralasertib | 1 |
| Darolutamide | 1 |
| Docetaxel | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 4 |
| Florida | 3 |
| Ohio | 3 |
| Tennessee | 3 |
| Arizona | 2 |
| Arkansas | 2 |
| California | 2 |
| Connecticut | 2 |
| Delaware | 2 |
| Georgia | 2 |
| Idaho | 2 |
| Illinois | 2 |
Top cities
Houston, Texas 4Columbus, Ohio 3Aberdeen, Maryland 2Ames, Iowa 2Ankeny, Iowa 2Ashland, Wisconsin 2Atlanta, Georgia 2Auburn, California 2Ballwin, Missouri 2Baltimore, Maryland 2
Self-screener
Recruiting trials
- Breast Cancer, Reasoning, and Activity Intervention
- Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
- Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
- Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
- Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
- Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
- Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Related conditions
Trials recruiting for Anatomic Stage IIIA Breast Cancer AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Anatomic Stage IIIC Breast Cancer AJCC v8 7Anatomic Stage IIIB Breast Cancer AJCC v8 7Anatomic Stage II Breast Cancer AJCC v8 35Anatomic Stage III Breast Cancer AJCC v8 39Prognostic Stage IIIC Breast Cancer AJCC v8 6Prognostic Stage IIIB Breast Cancer AJCC v8 5Prognostic Stage IIIA Breast Cancer AJCC v8 5Prognostic Stage III Breast Cancer AJCC v8 5Anatomic Stage IV Breast Cancer AJCC v8 43
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Anatomic Stage IIIA Breast Cancer AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.